In late October, the Biden Administration unveiled an executive order aimed at prioritizing the responsible use of artificial intelligence (AI), focusing on safety, security, privacy, equity, and innovation across various sectors. Under the authority of the Defense Production Act, the executive order mandates that AI developers disclose safety test outcomes and relevant data to the government. Simultaneously, the National Institute of Standards and Technology will be tasked with establishing criteria to guarantee the safety and security of AI tools before they are made available to the public. Additionally, the Department of Commerce will be responsible for releasing directives aimed at marking and distinguishing AI-generated content through labeling and watermarking. This multifaceted order covers a wide array of additional concerns related to privacy, civil rights, consumer safeguards, scientific research, and labor rights.
Within the healthcare realm, the order aims to ensure the safe and effective use of AI in healthcare, targeting the development of affordable and life-saving drugs. To that end, the Department of Health and Human Services (HHS) is directed to establish a strategy for regulating the use of AI and AI-enabled tools in drug development processes. HHS is also directed to prioritize grantmaking that favors responsible AI development, as well as collaborate with the Secretary of Defense and Veterans Affairs to create a strategic plan on the responsible deployment of AI and AI-enabled technologies. The intersection of AI with telehealth is currently most evident in how AI can impact medical diagnosis, treatment, and patient care that happens to be delivered through a telehealth modality.
LEARN MORE – AMERICAN TELEMEDICINE ASSOCIATION (ATA) ARTIFICIAL INTELLIGENCE PRINCIPLES
Posted In: Resource Information